Supra-plasma expanders: the future of treating blood loss and anemia without red cell transfusions? 2015

Amy G Tsai, and Beatriz Y Salazar Vázquez, and Axel Hofmann, and Seetharama A Acharya, and Marcos Intaglietta
University of California, San Diego, Department of Bioengineering, La Jolla, California (Drs Tsai, Salazar Vázquez, and Intaglietta); Universidad Nacional Autónoma de México, Hospital General de México "Dr. Eduardo Liceaga," Department of Experimental Medicine, México DF, México (Dr Salazar Vázquez); Universidad Juárez del Estado de Durango, Victoria de Durango, Faculty of Medicine, Dgo, Mexico (Dr Salazar Vázquez); University Hospital, Institute of Anesthesiology, Zürich, Switzerland (Dr Hofmann); University of Western Australia, School of Surgery, Perth, Australia (Dr Hofmann); and Albert Einstein College of Medicine, Department of Hematology and Medicine, Bronx, New York (Dr Acharya). Amy G. Tsai, PhD, is a research scientist and principal investigator in the Department of Bioengineering of the University of California, San Diego. She specializes in the study of in vivo microvascular responses to hemorrhagic shock and acute anemia, with the aim of developing new resuscitation fluids, next-generation plasma expanders, and oxygen carriers. Beatriz Y. Salazar Vázquez, MD, PhD, is a visiting scholar at the University of California, San Diego, and a research scientist at the Universidad Nacional Autónoma de México, where she studies the cardiovascular effects of hematocrit changes. Axel Hofmann, ME, is a visiting professor at the Institute of Anesthesiology at University Hospital in Zürich, Switzerland, and an adjunct associate professor in the School of Surgery at the University of Western Australia. Seetharama A. Acharya, PhD, is a professor of hematology and biophysics at the Albert Einstein College of Medicine in New York. He is an expert on protein peglylation design as applied to its use as blood replacement fluids. Marcos Intaglietta, PhD, is a distinguished professor of bioengineering at the University of California, San Diego, and is an authority in the analysis of the microcirculation and how it behaves during changes of blood composition resul

Oxygen delivery capacity during profoundly anemic conditions depends on blood's oxygen-carrying capacity and cardiac output. Oxygen-carrying blood substitutes and blood transfusion augment oxygen-carrying capacity, but both have given rise to safety concerns, and their efficacy remains unresolved. Anemia decreases oxygen-carrying capacity and blood viscosity. Present studies show that correcting the decrease of blood viscosity by increasing plasma viscosity with newly developed plasma expanders significantly improves tissue perfusion. These new plasma expanders promote tissue perfusion, increasing oxygen delivery capacity without increasing blood oxygen-carrying capacity, thus treating the effects of anemia while avoiding the transfusion of blood.

UI MeSH Term Description Entries
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D010952 Plasma Substitutes Any liquid used to replace blood plasma, usually a saline solution, often with serum albumins, dextrans or other preparations. These substances do not enhance the oxygen- carrying capacity of blood, but merely replace the volume. They are also used to treat dehydration. Blood Expanders,Plasma Volume Expanders,Expanders, Blood,Expanders, Plasma Volume,Substitutes, Plasma,Volume Expanders, Plasma
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000740 Anemia A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN. Anemias
D017707 Erythrocyte Transfusion The transfer of erythrocytes from a donor to a recipient or reinfusion to the donor. Red Blood Cell Transfusion,Red Blood Cell Transfusions,Transfusion, Red Blood Cell,Transfusions, Red Blood Cell,Erythrocyte Transfusions,Transfusion, Erythrocyte,Transfusions, Erythrocyte

Related Publications

Amy G Tsai, and Beatriz Y Salazar Vázquez, and Axel Hofmann, and Seetharama A Acharya, and Marcos Intaglietta
October 1954, The Surgical clinics of North America,
Amy G Tsai, and Beatriz Y Salazar Vázquez, and Axel Hofmann, and Seetharama A Acharya, and Marcos Intaglietta
May 1990, Seminars in oncology nursing,
Amy G Tsai, and Beatriz Y Salazar Vázquez, and Axel Hofmann, and Seetharama A Acharya, and Marcos Intaglietta
February 2018, Seminars in pediatric surgery,
Amy G Tsai, and Beatriz Y Salazar Vázquez, and Axel Hofmann, and Seetharama A Acharya, and Marcos Intaglietta
October 2015, MLO: medical laboratory observer,
Amy G Tsai, and Beatriz Y Salazar Vázquez, and Axel Hofmann, and Seetharama A Acharya, and Marcos Intaglietta
October 1952, Minnesota medicine,
Amy G Tsai, and Beatriz Y Salazar Vázquez, and Axel Hofmann, and Seetharama A Acharya, and Marcos Intaglietta
April 2006, Journal of thrombosis and thrombolysis,
Amy G Tsai, and Beatriz Y Salazar Vázquez, and Axel Hofmann, and Seetharama A Acharya, and Marcos Intaglietta
July 2001, Transfusion medicine reviews,
Amy G Tsai, and Beatriz Y Salazar Vázquez, and Axel Hofmann, and Seetharama A Acharya, and Marcos Intaglietta
January 1993, The Journal of the Florida Medical Association,
Amy G Tsai, and Beatriz Y Salazar Vázquez, and Axel Hofmann, and Seetharama A Acharya, and Marcos Intaglietta
April 1970, JAMA,
Amy G Tsai, and Beatriz Y Salazar Vázquez, and Axel Hofmann, and Seetharama A Acharya, and Marcos Intaglietta
September 1970, JAMA,
Copied contents to your clipboard!